(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Casey's Misses Estimates; Potential Upside In Focus: Petrobras, Glaukos, Terns Pharma, Amazon, Netflix

  • June 07th, 2023
  • 663 views

Casey's General Stores, Inc. (Nasdaq: CASY) announced its financial results for the fourth quarter of fiscal year 2023. The company reported earnings per share (EPS) of $1.49, which fell short of the consensus estimate of $1.59. 

Following the earnings release, $CASY experienced a decline of 4.52%, trading at $214.13 in after-hours on Tuesday.

Petróleo Brasileiro S.A. - Petrobras (NYSE: PBR), a Brazilian multinational energy company, has been upgraded by Morgan Stanley from Equal-Weight to Overweight, with a raised price target of $16.5 compared to the previous target of $12.5. 

Based on Tuesday's closing price of $12.65, this adjusted price target indicates a potential upside of approximately $3.85 or around 30.47% for $PBR, as per Morgan Stanley's assessment.

Glaukos Corporation (NYSE: GKOS), a medical technology and pharmaceutical company, has received an upgrade from Piper Sandler, shifting from Neutral to Overweight, along with a raised price target of $80, up from $55. 

With $GKOS closing at $64.82 on Tuesday, this suggests a potential upside of about $15.18 or roughly 23.41% based on Piper Sandler's view.

Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a biopharmaceutical company focused on discovering and developing innovative therapies, has been initiated with a Buy rating by Jefferies, accompanied by a price target of $18. 

With Tuesday's closing price of $11.63, this price target implies a potential upside of approximately $6.37 or around 54.76% for $TERN, according to Jefferies' analysis.

Amazon.com, Inc. (Nasdaq: AMZN), a global e-commerce and technology company, is being maintained with an Overweight rating by Piper Sandler, along with a raised price target of $150, up from $130. 

With $AMZN closing at $126.61 on Tuesday, this suggests a potential upside of about $23.39 or roughly 18.48% based on Piper Sandler's outlook.

Netflix, Inc. (Nasdaq: NFLX), a leading entertainment streaming platform, is being maintained with an Overweight rating by JP Morgan, accompanied by a raised price target of $470, up from $380. 

Based on Tuesday's closing price of $399.29, this implies a potential upside of approximately $70.71 or around 17.75% for $NFLX, according to JP Morgan's analysis.

It is important to note that the potential upside mentioned for each company is derived from the assessment of the respective brokerage firm, investment firm, or analysts. Investors are advised to perform their own research, evaluate additional factors, and exercise due diligence before making any investment decisions.

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13